Home » Topics » Regulatory

Regulatory
RSS

FDA approves Emend for prevention of postoperative nausea and vomiting

July 12, 2006

Avandamet approved for initial treatment of type 2 diabetes

July 12, 2006

Revlimid approved for use in multiple myeloma

June 30, 2006

Sprycel approved for two new indications

June 29, 2006

Accelerated approval for Prezista in HIV combination therapy

June 26, 2006

European approval of Acomplia

June 23, 2006

Avastin approved for second-line use in metastatic colorectal cancer

June 21, 2006

Hycamtin approved for use with cisplatin in cervical cancer

June 19, 2006

Humira approved in Europe for ankylosing spondylitis

June 8, 2006

Betaferon approved in Europe as first-line treatment for earliest stages of MS

June 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...